|
|
||||||||
1 Mayo Medical School, Mayo Clinic, Rochester, MN.
2 Department of Radiology, Mayo Clinic Rochester, 200 First St. SW, Rochester,
MN 55905.
3 Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester,
MN.
4 Division of Biostatistics, Mayo Clinic, Rochester, MN.
5 Department of Internal Medicine, Division of Gastroenterology, Mayo Clinic,
Rochester, MN.
OBJECTIVE. The purposes of our study were to describe the CT appearance of recurrent intraductal papillary mucinous neoplasms of the pancreas after surgical resection and estimate the performance of CT in detecting recurrent neoplasms.
MATERIALS AND METHODS. A single unblinded reviewer characterized the presence and appearance of recurrent intraductal papillary mucinous neoplasms on 66 CT scans of 17 patients with proven recurrence, noting location and appearance of recurrent neoplasm. These results, described in this article, were summarized in tabular format and shown to three blinded observer. The observers then evaluated one postoperative CT examination from every patient at our institution who underwent surgical removal of intraductal papillary mucinous neoplasms (n = 45) for the presence or absence of local or distant recurrence.
RESULTS. The unblinded reviewer found 11 cases of local recurrence.
Extrapancreatic local recurrences tend to have solid components (5/6), tend to
be located adjacent to the resection margin (5/6), and may exhibit vascular
invasion (2/6). Intrapancreatic neoplasms are usually cystic (4/5). Nine
patients had distant metastases. Prospective sensitivity for recurrent tumor
ranged from 76% (13/17) to 94% (16/17). Sensitivity for local recurrence
ranged from 55% (6/11) to 82% (9/11). Specificity ranged from 79% (22/28) to
96% (27/28). Interobserver agreement for predicting recurrence was moderate to
substantial (
= 0.51-0.65).
CONCLUSION. Locally recurrent intraductal papillary mucinous neoplasms of the pancreas tend to be either extrapancreatic and solid at the resection margin or intrapancreatic and cystic. CT can detect most recurrent intraductal papillary mucinous neoplasms of the pancreas with moderate to substantial interobserver agreement.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. F. Akisik, K. Sandrasegaran, A. A. Aisen, D. D. T. Maglinte, S. Sherman, and G. A. Lehman Dynamic secretin-enhanced MR cholangiopancreatography. RadioGraphics, May 1, 2006; 26(3): 665 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kawamoto, K. M. Horton, L. P. Lawler, R. H. Hruban, and E. K. Fishman Intraductal Papillary Mucinous Neoplasm of the Pancreas: Can Benign Lesions Be Differentiated from Malignant Lesions with Multidetector CT? RadioGraphics, November 1, 2005; 25(6): 1451 - 1468. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |